Hexarelin
A growth hormone secretagogue and ghrelin-receptor agonist that remains a familiar legacy name in GH-peptide stacks.
Also appears in: Hormone
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
Primary lane: Growth Hormone. Also surfaces under Hormone for browsing and discovery.
No major aliases are tracked for this profile yet.
No FDA label signal · 0 trials · 288 PubMed results
What hexarelin is
Hexarelin is a growth hormone secretagogue and ghrelin-receptor agonist that predates many of the newer GH-related peptide stacks now discussed online.
Why it matters
It belongs in the library because it is still a recognizable legacy name alongside compounds like GHRP-2, GHRP-6, and ipamorelin.
Regulatory context
Hexarelin is not FDA approved for routine consumer therapeutic use in the United States. It fits best in the research-market category.
Practical reading note
Hexarelin helps show the older side of the GH-secretagogue ecosystem, which is useful context when newer peptides get marketed as if they appeared from nowhere.